The company's stock is in the consolidation stage strongly The stock is now buy I do not recommend Stop Loss because you will be taken out by the market makers I cannot say more details about my strategy as it is very confidential
The company's stock is in the consolidation stage strongly The stock is now buy I do not recommend Stop Loss because you will be taken out by the market makers I cannot say more details about my strategy as it is very confidential
Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders.
Industry standard earnings growth gives me a Price target of $7.30. Of course it may take a while to get there. PERFORMANCE TECHNOLOGIES INC \DE\ Financials read full: finance.yahoo.com